Journal
MOLECULAR CANCER RESEARCH
Volume 19, Issue 3, Pages 485-497Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-20-0414
Keywords
-
Categories
Funding
- NIH/NCI CCSG [P30CA016672]
- NIH/NCI [R01-CA207295, T32 CA009666]
- University of Texas-Southwestern and MD Anderson Cancer Center Lung SPORE [5 P50 CA070907]
- ASCO Young Investigator Award
- LUNGevity foundation
- MD Anderson Cancer Center Physician Scientist Award
- Andrew Sabin Family Fellowship
- Rexanna Foundation for Fighting Lung Cancer
Ask authors/readers for more resources
AXL, a TAM family receptor tyrosine kinase, plays a significant role in determining resistance to targeted therapies in NSCLC and other cancers. High levels of AXL and epithelial-to-mesenchymal transition are associated with subsets of treatment-naive and treatment-relapsed NSCLC. Combined inhibition of AXL and ATR significantly decreases cell proliferation of NSCLC and LCNEC cell lines, inducing DNA damage and replication stress.
AXL, a TAM (TYRO3, AXL, and MERTK) family receptor tyrosine kinase, is increasingly being recognized as a key determinant of resistance to targeted therapies, as well as chemotherapy and radiation in non-small cell lung cancer (NSCLC) and other cancers. We further show here that high levels of AXL and epithelial-to-mesenchymal transition were frequently expressed in subsets of both treatment-naive and treatment-relapsed NSCLC. Previously, we and others have demonstrated a role for AXL in mediating DNA damage response (DDR), as well as resistance to inhibition of WEE1, a replication stress response kinase. Here, we show that BGB324 (bemcentinib), a selective small-molecule AXL inhibitor, caused DNA damage and induced replication stress, indicated by ATR/CHK1 phosphorylation, more significantly in TP53-deficient NSCLC cell lines. Similar effects were also observed in large-cell neuroendocrine carcinoma (LCNEC) cell lines. High AXL protein levels were also associated with resistance to ATR inhibition. Combined inhibition of AXL and ATR significantly decreased cell proliferation of NSCLC and LCNEC cell lines. Mechanistically, combined inhibition of AXL and ATR significantly increased RPA32 hyperphosphorylation and DNA double-strand breaks and induced markers of mitotic catastrophe. Notably, NSCLC cell lines with low levels of SLFN11, a known predictive biomarker for platinum and PARP inhibitor sensitivity, were more sensitive to AXL/ATR cotargeting. These findings demonstrate a novel and unexpected role for AXL in replication stress tolerance, with potential therapeutic implications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available